Drug profile · INN
amphetamine adipate
DELCOBESE
amphetamine adipate (DELCOBESE) is a dopamine transporter releasing agent. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — amphetamine adipate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 20
- Programs
- 2
- Data quality
- 0.89
Quick answer
amphetamine adipate (DELCOBESE) is a dopamine transporter releasing agent. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Dopamine transporter releasing agent
Primary target: Sodium-dependent dopamine transporter
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 12084350
Allotrope of carbon having increased electron delocalization
granted -
US 11933866
Magnetic resonance maps for analyzing brain tissue
granted -
US 11892530
Magnetic resonance maps for analyzing tissue
granted -
US 11820833
Peptides that inhibit binding of EPCR to its ligand to treat inflammation
granted -
US 11718530
Allotrope of carbon having increased electron delocalization
granted -
US 11497793
Compositions and methods for treating glioblastoma
granted -
US 11219636
Compositions and methods for treating cancer
granted -
US 10809323
Magnetic resonance maps for analyzing tissue
granted -
US 10738361
Methods of predicting clinical course and treating multiple sclerosis
granted -
US 10639350
Methods and pharmaceutical compositions for improving wound healing using CD24
granted -
US 10508136
Peptides and compositions for prevention of cell adhesion and methods of using same
granted -
US 10113170
Preventing and treating inflammatory skin diseases
granted -
US 10028999
PAR-1 based therapeutic conjugates and uses thereof
granted -
US 9777050
Peptides and compositions for prevention of cell adhesion and methods of using same
granted -
US 9771567
Klotho variant polypeptides
granted -
US 9758831
Methods of predicting clinical course and treating multiple sclerosis
granted -
US 9737571
Compositions of aquatic origin for prevention of cell adhesion and methods of using same
granted -
US 9732124
Peptides and compositions for prevention of cell adhesion and methods of using same
granted -
US 9481894
Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
granted -
US 9394569
Methods and kits for early detection of cancer or predisposition thereto
granted
Frequently asked questions
What is amphetamine adipate?
amphetamine adipate (DELCOBESE) is a dopamine transporter releasing agent. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for amphetamine adipate?
DELCOBESE is a marketed brand name for amphetamine adipate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of amphetamine adipate?
amphetamine adipate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.